Pharmacologic Management of Obesity in Neuro-Oncology: A Case Report.

Lardieri A, Thaker V, Citron-Zafrin K, Garvin JH, Zacharoulis S, Ladas EJ

Case reports in oncology17 Dec 2024

PMID39980512PMCIDPMC11785398DOI10.1159/000543178PepBankPUB-39980512

Read at source PubMedAsk about this study

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

01HumanCase report or seriesEfficacy outcome
In one 11-year-old girl with obesity after treatment for a brain tumor, significant weight loss followed semaglutide treatment.
In plain wordsOne 11-year-old girl with obesity after brain tumor treatment lost a lot of weight after starting semaglutide.
Peptide
Semaglutide
Outcome
DecreaseWeight loss
Study
n = 1
Outcome group
Body weight · Metabolic and weight
Studied dose
Dose not stated
Source sentences
Summary
Following treatment with semaglutide, significant weight loss was observed.
2 context sentences(design, population, supporting numbers)
Summary · context
We describe a case report of a 11-year-old female who underwent treatment for a ganglioglioma, WHO grade 1, and simultaneously experienced nearly 100-kg weight gain.
Summary · context
After several unsuccessful attempts at lifestyle interventions, she was referred to endocrinology and prescribed a GLP-1 receptor agonist, semaglutide.
Report a problemFND-3998051201
02HumanCase report or seriesEfficacy outcome
In one 11-year-old girl with obesity after treatment for a brain tumor, quality of life and social activity were reported as enhanced after semaglutide.
In plain wordsOne 11-year-old girl with obesity after brain tumor treatment reported better quality of life and more social activity on semaglutide.
Peptide
Semaglutide
Outcome
IncreaseQuality of life and social activity
Study
n = 1
Outcome group
Quality of life · Whole body
Studied dose
Dose not stated
Source sentences
Summary
Importantly, the patient reported enhanced quality of life and social activity.
2 context sentences(design, population, supporting numbers)
Summary · context
We describe a case report of a 11-year-old female who underwent treatment for a ganglioglioma, WHO grade 1, and simultaneously experienced nearly 100-kg weight gain.
Summary · context
After several unsuccessful attempts at lifestyle interventions, she was referred to endocrinology and prescribed a GLP-1 receptor agonist, semaglutide.
Report a problemFND-3998051202

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

Version 2Current
11 Oct 2026, 00:04 UTC
Study results updated
Version 1
9 Oct 2026, 03:06 UTC
First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

Keywords

PepBank is a research reference. Talk to a doctor before you use any peptide.